SCHEMBL6550737

SCHEMBL6550737

COc1ccc(C=CC(=O)O)c(CC(O)CNC(C)(C)C)c1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 2/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
ADRB2 P07550 4/20 0.39
ADRB1 P08588 4/20 0.39
ADRB3 P13945 4/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
HTR1A P08908 1/20 0.38
HTR2C P28335 1/20 0.38
GAA P10253 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA6 P23280 1/20 0.37
CA5A P35218 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6550733 1.00 NFE2L2 (0.40) NFE2L2ABCG2ADRB2ADRB1ADRB3
Hydrochloric Acid SCHEMBL6549870 0.83 ADRB2 (0.36) NFE2L2ABCG2ADRB2ADRB1ADRB3
SCHEMBL6550497 0.77 POLB (0.45) ABCG2KDM4EALDH1A1HPGDNPC1
SCHEMBL6550490 0.77 POLB (0.45) ABCG2KDM4EALDH1A1HPGDNPC1
SCHEMBL26046337 0.76 ABCG2 (0.51) NFE2L2ABCG2KDM4EALDH1A1HPGD
SCHEMBL7673620 0.75 ALDH1A1 (0.47) KDM4EALDH1A1HPGDGAASMN1; SMN2
SCHEMBL7673613 0.75 ALDH1A1 (0.47) KDM4EALDH1A1HPGDGAASMN1; SMN2
SCHEMBL6550965 0.73 ADRB2 (0.47) ADRB2ADRB1ADRB3CA1CA2
SCHEMBL6550971 0.73 ADRB2 (0.47) ADRB2ADRB1ADRB3CA1CA2
SCHEMBL3976762 0.72 CA1 (0.41) KDM4EALDH1A1HPGDHSD17B10HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500823-B1 ENERGY DEFICIENCY OF THE CELL CAUSED BY PARP INHIBITION, IN DIABETES COMPLICATIONS, IN OXYGEN DEFICIENT STATUS OF THE HEART AND BRAIN, IN NEURODEGENERATIVE DISEASES, IN THE TREATMENT OF AUTOIMMUNE AND/OR VIRAL DISEASES N-GENE RESEARCH LABORATORIES, INC. 2002-12-31 US claimed
EP-1115697-B1 UNSATURATED HYDROXIMIC ACID DERIVATIVES AS PARP INHIBITORS GENE KUTATO KFT N (HU) 2004-02-04 EP disclosed